Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer’s disease

OBJECTIVE: While acetylcholinesterase inhibitors, such as donepezil, galantamine, and rivastig-mine, are beneficial in treating behavioral symptoms of patients with Alzheimer’s disease (AD), their dose-limiting effects include gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. We...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kano, Osamu, Urita, Yoshihisa, Ito, Hirono, Takazawa, Takanori, Kawase, Yuji, Murata, Kiyoko, Hirayama, Takehisa, Miura, Ken, Ishikawa, Yuichi, Kiyozuka, Tetsuhito, Aoyagi, Jo, Iwasaki, Yasuo
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3788693/
https://ncbi.nlm.nih.gov/pubmed/24092978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S50135
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky